Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter Registry

Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis

(2019) Hee Jin Park et al.   BMC GASTROENTEROLOGY

Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association

(2018) Lin Y. Chen et al.   CIRCULATION

Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

(2018) Daniele Pastori et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　― Findings From the SAKURA AF Registry ―

(2018) Yasuo Okumura et al.   CIRCULATION JOURNAL

Liver Disease as a Predictor of New‐Onset Atrial Fibrillation

(2018) William A. Huang et al.   Journal of the American Heart Association

Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study

(2018) Seung Up Kim et al.   Modern Rheumatology

Atrial fibrillation: Utility of CHADS 2 and CHA 2 DS 2 -VASc scores as predictors of readmission, mortality and resource utilization

(2017) Sopan Lahewala et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cirrhosis is a risk factor for atrial fibrillation: A nationwide, population-based study

(2017) HyunJung Lee et al.   LIVER INTERNATIONAL

Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)

(2015) Aki J. Käräjämäki et al.   PLoS One

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013)

(2014)   CIRCULATION JOURNAL

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

(2012) Yoshio Sumida et al.   BMC GASTROENTEROLOGY

Chronic Kidney Disease and CHADS2 Score Independently Predict Cardiovascular Events and Mortality in Patients With Nonvalvular Atrial Fibrillation

(2011) Keiko Nakagawa et al.   AMERICAN JOURNAL OF CARDIOLOGY

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

(2010) Thierry Poynard et al.   BMC GASTROENTEROLOGY

Update on the Association of Inflammation and Atrial Fibrillation

(2010) PARAG PATEL et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

(2009) Alan S. Go et al.   CIRCULATION

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Epidemiology of atrial fibrillation

(2009) Michael W. Rich   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY